Vaccine Overview
Hepatitis B Vaccine (rDNA) I.P.
This recombinant DNA vaccine provides protection against hepatitis B, a serious liver infection caused by the hepatitis B virus (HBV). It is administered intramuscularly in a series of three doses, typically starting at birth. The vaccine contains HBsAg antigen produced in yeast cells, ensuring a safe and effective immune response. It is a critical part of newborn and high-risk adult immunization schedules, helping prevent chronic liver disease, cirrhosis, and hepatocellular carcinoma.
Drug Class: Recombinant and other Products
Indication: Prevention of hepatitis B infection, including chronic liver disease, cirrhosis, and hepatocellular carcinoma.
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
Birth, then at 6 weeks and 6 months
Administration
Route: Intramuscular
Site: Anterolateral thigh (infants), deltoid (older)
Disease
Hepatitis B
Manufacturer
Serum Intitute Of India
Age
- From birth onward
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025